JP2014527025A - 吸入用一酸化窒素を用いて血管反応性を決定する方法 - Google Patents

吸入用一酸化窒素を用いて血管反応性を決定する方法 Download PDF

Info

Publication number
JP2014527025A
JP2014527025A JP2014512110A JP2014512110A JP2014527025A JP 2014527025 A JP2014527025 A JP 2014527025A JP 2014512110 A JP2014512110 A JP 2014512110A JP 2014512110 A JP2014512110 A JP 2014512110A JP 2014527025 A JP2014527025 A JP 2014527025A
Authority
JP
Japan
Prior art keywords
patient
vasoactive agent
right ventricular
indicator
hemodynamics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2014512110A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014527025A5 (cg-RX-API-DMAC7.html
Inventor
ワッツ タミー
エフ.ロスシグノ ロベルト
エイチ.フイネ ダビド
ジェイ.ルビン ルイス
Original Assignee
ゲノ エルエルシー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ゲノ エルエルシー filed Critical ゲノ エルエルシー
Publication of JP2014527025A publication Critical patent/JP2014527025A/ja
Publication of JP2014527025A5 publication Critical patent/JP2014527025A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/02—Detecting, measuring or recording for evaluating the cardiovascular system, e.g. pulse, heart rate, blood pressure or blood flow
    • A61B5/026—Measuring blood flow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00—Devices for influencing the respiratory system of patients by gas treatment, e.g. ventilators; Tracheal tubes
    • A61M16/10—Preparation of respiratory gases or vapours
    • A61M16/12—Preparation of respiratory gases or vapours by mixing different gases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Pathology (AREA)
  • Anesthesiology (AREA)
  • Physics & Mathematics (AREA)
  • Medical Informatics (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Emergency Medicine (AREA)
  • Biophysics (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2014512110A 2011-05-27 2012-05-24 吸入用一酸化窒素を用いて血管反応性を決定する方法 Pending JP2014527025A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161490929P 2011-05-27 2011-05-27
US61/490,929 2011-05-27
PCT/US2012/039401 WO2012166534A1 (en) 2011-05-27 2012-05-24 Method of determining vasoreactivity using inhaled nitric oxide

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017061811A Division JP2017165731A (ja) 2011-05-27 2017-03-27 吸入用一酸化窒素を用いて血管反応性を決定する方法

Publications (2)

Publication Number Publication Date
JP2014527025A true JP2014527025A (ja) 2014-10-09
JP2014527025A5 JP2014527025A5 (cg-RX-API-DMAC7.html) 2015-08-27

Family

ID=47259769

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2014512110A Pending JP2014527025A (ja) 2011-05-27 2012-05-24 吸入用一酸化窒素を用いて血管反応性を決定する方法
JP2017061811A Ceased JP2017165731A (ja) 2011-05-27 2017-03-27 吸入用一酸化窒素を用いて血管反応性を決定する方法
JP2019035311A Pending JP2019131556A (ja) 2011-05-27 2019-02-28 吸入用一酸化窒素を用いて血管反応性を決定する方法

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2017061811A Ceased JP2017165731A (ja) 2011-05-27 2017-03-27 吸入用一酸化窒素を用いて血管反応性を決定する方法
JP2019035311A Pending JP2019131556A (ja) 2011-05-27 2019-02-28 吸入用一酸化窒素を用いて血管反応性を決定する方法

Country Status (6)

Country Link
US (1) US11154210B2 (cg-RX-API-DMAC7.html)
EP (1) EP2713723B1 (cg-RX-API-DMAC7.html)
JP (3) JP2014527025A (cg-RX-API-DMAC7.html)
AU (1) AU2012262534B2 (cg-RX-API-DMAC7.html)
CA (1) CA2837341C (cg-RX-API-DMAC7.html)
WO (1) WO2012166534A1 (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019513691A (ja) * 2016-02-12 2019-05-30 マリンクロット ホスピタル プロダクツ アイピー リミテッド 吸入用一酸化窒素の左心補助人工心臓への使用とモニタリング

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2006023616A2 (en) * 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
AU2009209181B2 (en) 2008-01-28 2014-01-16 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
US8613958B2 (en) 2009-06-22 2013-12-24 Geno Llc Nitric oxide therapies
AU2012262534B2 (en) 2011-05-27 2016-06-02 VERO Biotech LLC. Method of determining vasoreactivity using inhaled nitric oxide
WO2015160777A1 (en) 2014-04-15 2015-10-22 Commscope Technologies Llc Wideband remote unit for distributed antenna system
JP6704094B2 (ja) 2017-02-27 2020-06-03 サード ポール, インコーポレイテッドThird Pole, Inc. 酸化窒素を生成するためのシステムおよび方法
MX2019009931A (es) 2017-02-27 2020-07-14 Third Pole Inc Sistemas y metodos para generacion ambulatoria de oxido nitrico.
MX2020010523A (es) 2017-02-27 2021-02-09 Third Pole Inc Sistemas y metodos para generar oxido nitrico.
US11672938B1 (en) 2018-07-18 2023-06-13 Vero Biotech LLC Start-up protocols for nitric oxide delivery device
WO2020074957A1 (en) * 2018-10-12 2020-04-16 Sanotize Research And Development Corp. Gas-evolving compositions and container and delivery systems
WO2020232414A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Architectures for production of nitric oxide
WO2020232419A1 (en) 2019-05-15 2020-11-19 Third Pole, Inc. Systems and methods for generating nitric oxide
EP3969415A4 (en) 2019-05-15 2023-08-16 Third Pole, Inc. ELECTRODES FOR GENERATING NITROUS OXIDE
EP4069069A4 (en) 2020-01-11 2024-07-03 Third Pole, Inc. SYSTEMS AND METHODS FOR NITROGEN OXIDE PRODUCTION WITH HUMIDITY CONTROL
EP4167920A4 (en) 2020-06-18 2024-06-12 Third Pole, Inc. Systems and methods for preventing and treating infections with nitric oxide
WO2022082072A1 (en) 2020-10-16 2022-04-21 Third Pole, Inc. Nitric oxide generation process controls
WO2023049873A1 (en) 2021-09-23 2023-03-30 Third Pole, Inc. Systems and methods for delivering nitric oxide
US12569628B2 (en) 2022-04-14 2026-03-10 Third Pole, Inc. Delivery of medicinal gas in a liquid medium

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523090A (ja) * 2004-12-08 2008-07-03 バイオマリン ファーマシューティカル インコーポレイテッド 新生児肺高血圧症の治療のための方法および組成物
JP2011010865A (ja) * 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
WO2011063335A1 (en) * 2009-11-20 2011-05-26 Geno Llc Nitric oxide delivery system

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6758214B2 (en) 2000-01-28 2004-07-06 Cyterra Corporation Simple nitric oxide generator for ambulatory and/or bedside inhaled no treatment
US7040313B2 (en) 2001-09-05 2006-05-09 Cyterra Corporation Method and apparatus for nitric oxide generation
US7618594B2 (en) 2004-08-18 2009-11-17 Geno Llc Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2006023616A2 (en) 2004-08-18 2006-03-02 Geno Llc Conversion of nitrogen dioxide (no2) to nitric oxide (no)
WO2007087575A2 (en) * 2006-01-24 2007-08-02 University Of Chicago Compositions and methods for treating pulmonary hypertension
AU2008232413B2 (en) 2007-03-23 2013-09-19 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
AU2009209181B2 (en) 2008-01-28 2014-01-16 VERO Biotech LLC. Conversion of nitrogen dioxide (NO2) to nitric oxide (NO)
WO2010011928A1 (en) 2008-07-24 2010-01-28 Geno Llc Methods for diagnosing and treating a heart condition in a patient
US10780241B2 (en) 2008-08-21 2020-09-22 Vero Biotech LLC Devices and methods for minimizing and treating high-altitude sickness
US10960168B2 (en) 2008-08-21 2021-03-30 Vero Biotech LLC Delivery of high concentration nitric oxide
US8701657B2 (en) 2008-08-21 2014-04-22 Geno Llc Systems for generating nitric oxide
US8607785B2 (en) 2008-08-21 2013-12-17 Geno Llc Systems and devices for generating nitric oxide
EP2362810A4 (en) 2008-09-22 2013-09-11 Geno Llc CONVERSION OF NITROGEN DIOXIDE (NO2) TO NITROGEN MONOXIDE (NO)
US8613958B2 (en) 2009-06-22 2013-12-24 Geno Llc Nitric oxide therapies
US20120093948A1 (en) * 2009-11-20 2012-04-19 Fine David H Nitric Oxide Treatments
WO2011137122A1 (en) 2010-04-26 2011-11-03 Geno Llc Nitrosyl special connector
CA2797702C (en) 2010-04-26 2020-03-10 VERO Biotech LLC. Delivery of ultra pure nitric oxide (no)
USD688352S1 (en) 2010-04-27 2013-08-20 Geno Llc Female gas connector
USD679366S1 (en) 2010-04-27 2013-04-02 Geno Llc Male gas connector
EP2645860A4 (en) * 2010-12-03 2014-07-09 Geno Llc NITROGEN OXIDE TREATMENTS
US20140051737A1 (en) * 2011-05-10 2014-02-20 Universite Laval Methods for the treatment and diagnostic of pulmonary arterial hypertension
AU2012262534B2 (en) 2011-05-27 2016-06-02 VERO Biotech LLC. Method of determining vasoreactivity using inhaled nitric oxide
EP4180078A1 (en) 2014-10-20 2023-05-17 VERO Biotech LLC Nitrogen dioxide storage cassette

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008523090A (ja) * 2004-12-08 2008-07-03 バイオマリン ファーマシューティカル インコーポレイテッド 新生児肺高血圧症の治療のための方法および組成物
JP2011010865A (ja) * 2009-06-30 2011-01-20 Ikaria Holdings Inc 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法
WO2011063335A1 (en) * 2009-11-20 2011-05-26 Geno Llc Nitric oxide delivery system

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JPN5014007396; Advances in Pulmonary Hypertension Vol.4,No.3, 2005, p15-25 *
JPN6016006437; Japanese Circulation Journal Vol.59,No.Suppl.I, 1995, p391 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2019513691A (ja) * 2016-02-12 2019-05-30 マリンクロット ホスピタル プロダクツ アイピー リミテッド 吸入用一酸化窒素の左心補助人工心臓への使用とモニタリング

Also Published As

Publication number Publication date
JP2019131556A (ja) 2019-08-08
EP2713723B1 (en) 2018-09-12
WO2012166534A1 (en) 2012-12-06
JP2017165731A (ja) 2017-09-21
CA2837341C (en) 2021-10-19
US11154210B2 (en) 2021-10-26
US20130309328A1 (en) 2013-11-21
AU2012262534A1 (en) 2013-12-12
EP2713723A1 (en) 2014-04-09
AU2012262534B2 (en) 2016-06-02
EP2713723A4 (en) 2015-03-25
CA2837341A1 (en) 2012-12-06

Similar Documents

Publication Publication Date Title
JP2019131556A (ja) 吸入用一酸化窒素を用いて血管反応性を決定する方法
JP3248533B2 (ja) 呼気中のnoレベルの測定に使用されるシステムおよび異常noレベルに関連する疾患の診断方法
Gómez et al. Effects of nebulized NG‐nitro‐L‐arginine methyl ester in patients with hepatopulmonary syndrome
US10362981B2 (en) Diagnostic methods and systems based on urine analysis
Bihari et al. Bolus intravenous 0.9% saline, but not 4% albumin or 5% glucose, causes interstitial pulmonary edema in healthy subjects
Fülesdi et al. Cerebral vasoreactivity to acetazolamide is not impaired in patients with severe sepsis
Casey et al. Vasoconstrictor responsiveness during hyperbaric hyperoxia in contracting human muscle
Prasad et al. Increased chemiluminescence of polymorphonuclear leucocytes in dogs with volume overload heart failure
Colle et al. Hepatopulmonary syndrome and portopulmonary hypertension: what’s new
Casey et al. Hyperbaric hyperoxia reduces exercising forearm blood flow in humans
Lahzami et al. Small airways function declines after allogeneic haematopoietic stem cell transplantation
Valenzuela et al. Cardiac function in critically ill patients with severe COVID: A prospective cross-sectional study in mechanically ventilated patients
JP2009516534A5 (cg-RX-API-DMAC7.html)
Yu et al. Intradialytic systolic blood pressure variation can predict long-term mortality in patients on maintenance hemodialysis
Bulte et al. Myocardial blood flow under general anaesthesia with sevoflurane in type 2 diabetic patients: a pilot study
Heyman et al. Intrarenal nitric oxide monitoring with a Clark-type electrode: potential pitfalls
Cruz Jr et al. Effects of intra-aortic balloon occlusion on intestinal perfusion, oxygen metabolism and gastric mucosal PCO2 during experimental hemorrhagic shock
Lehtipalo et al. Effects of positive end‐expiratory pressure on intestinal circulation during graded mesenteric artery occlusion
RU2319961C1 (ru) Способ прогнозирования течения туберкулеза легких
Evans Molecular evidence for blood-brain barrier disruption in the absence of structural tissue damage during acute exposure to inspiratory hypoxia
JP2015102414A (ja) ヘリコバクター・ピロリの検出方法及び検出器具
US20050196868A1 (en) Use of free hemoglobin and its surrogate markers to detect and monitor pulmonary hypertension
Courtice The gaseous tensions in the brain
Moran et al. Hemodynamic effects of prolonged hyperoxia
RU2316254C1 (ru) Способ прогнозирования нестабильного течения бронхиальной астмы

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150521

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150701

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160223

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160519

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160823

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161129